Oncology is changing: the challenge of effectively assessing response within clinical trials in low-grade gliomas

• Auteurs principaux: Ilaria Imarisio (Auteur), Chiara Fumagalli (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2011-06-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

The current WHO classification of primary central nervous system (CNS) tumors recognizes four separate tumor grades (I-IV), which can be grouped into low-grade (I and II) or high-grade (III and IV), depending on the absence or presence of high-grade histopathological features, such as microvascular...